Fidson Healthcare Plc has enhanced its equity base by listing an additional 600 million ordinary shares, each with a nominal value of 50 kobo, on the Nigerian Exchange Limited (NGX).
This listing follows the successful completion of a rights issue aimed at raising capital for the company’s future expansion initiatives.
The newly issued shares were priced at N35.00 each and were made available to existing shareholders on the basis of one new share for every four shares held as of November 12, 2025.
In the weekly report of NGX stated that “the shares were officially admitted to the daily official list of the Exchange on June 2, 2026. As a result of this rights issue, Fidson Healthcare’s total issued and fully paid-up share capital has increased from 2.4 billion ordinary shares to a substantial three billion ordinary shares.
“This increase is aimed at bolstering the company’s capital base, providing it with the necessary resources to fund further expansion and enhance its competitive position in the healthcare sector.”
Recently, the managing director and chief executive officer, Mr. Biola Adebayo, said the rights issue represents a major milestone in Fidson’s growth journey.
“The funds will further strengthen our position as Nigeria’s foremost healthcare company and accelerate our emergence as a dominant player across Africa. Our performance this year demonstrates our resilience and capacity to grow, and this capital will enable us to create sustainable long-term value for our stakeholders,” Adebayo said.
